Jones Margaret E E ME

Show results for

Unknown (17)
Transcriptomics (1)
Metabolomics (1)

Organisms

Mus musculus (1)

Repository

biostudies-arrayexpress (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2008 (1)
2023 (1)

CHEBI ID

CHEBI:116314 (1)
CHEBI:132244 (1)
CHEBI:132583 (1)
CHEBI:139445 (1)
CHEBI:143106 (1)
CHEBI:143235 (1)
CHEBI:15354 (1)
CHEBI:15694 (1)
CHEBI:15728 (1)
CHEBI:15746 (1)
CHEBI:15756 (1)
CHEBI:15890 (1)
CHEBI:15940 (1)
CHEBI:15971 (1)
CHEBI:16015 (1)
CHEBI:16027 (1)
CHEBI:16040 (1)
CHEBI:16235 (1)
CHEBI:16259 (1)
CHEBI:16264 (1)
CHEBI:16269 (1)
CHEBI:16335 (1)
CHEBI:16393 (1)
CHEBI:16436 (1)
CHEBI:16523 (1)
CHEBI:165632 (1)
CHEBI:16610 (1)
CHEBI:16634 (1)
CHEBI:166563 (1)
CHEBI:16695 (1)

Metabolite Name

(+/-)12(13)-DiHOME (1)
(+/-)9-HpODE (1)
(15Z)-9,12,13-Trihydroxy-15-octadecenoic acid (1)
2,5-di-tert-Butylhydroquinone (1)
AICA ribonucleotide (1)
Adenosine (1)
Adenosine 5'-monophosphate (1)
Adenosine diphosphate (ADP) (1)
Azelaic acid (1)
Citric acid (1)
Cyclic ADP-ribose (1)
Cytidine (1)
D-Raffinose (1)
DL-Tryptophan (1)
Dibutyl phthalate (1)
Dodecanedioic acid (1)
Folic acid (1)
Gluconic acid (1)
Guanosine (1)
Guanosine monophosphate (GMP) (1)
Hexadecanedioic acid (1)
L-Glutathione (reduced) (1)
L-Glutathione oxidized (1)
N-Acetyl-1-aspartylglutamic acid (1)
N-Acetyl-L-phenylalanine (1)
Palmitic acid (1)
Pantothenic acid (1)
S-Lactoylglutathione (1)
Tetradecanedioic acid (1)
Thymidine (1)

Study type

Transcription profiling by array (1)

Release Date

2024 (3)
2022 (3)
2021 (3)
2020 (2)
2019 (2)
2015 (2)
2008 (1)
2023 (1)
2017 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Implementation of a Novel Electronic Patient-Directed Smoking Cessation Platform for Cancer Patients: Interrupted Time Series Analysis.

Not available

S-EPMC6477574 | biostudies-literature

Transcription profiling of mouse CD34-enriched keratinocyte stem cells

Recent developments in animal models (Morris et al., 2004; Tumbar et al., 2004) as well as the discovery of cell surface markers (Jones and Watt, 1993; Tani et al., 2000; Trempus et al., 2003; Nijhof et al., 2006) have made it possible to isolate living epidermal hair follicle stem cells (HFSCs) fro...

ORGANISM(S): Mus musculus

2008-06-15 | E-GEOD-7690 | biostudies-arrayexpress

FSCN1 as a new druggable target in adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a high risk of relapse and metastatisation. The actin-bundling protein fascin (FSCN1) is overexpressed in aggressive ACC and represents a reliable prognostic indicator. FSCN1 has been shown to synergize with the Rho/Rac GEF VAV2 i...

2023-03-20 | MTBLS6402 | MetaboLights

Connecting breast cancer survivors for exercise: protocol for a two-arm randomized controlled trial.

Not available

S-EPMC8515152 | biostudies-literature

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.

Not available

S-EPMC7616360 | biostudies-literature

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.

Not available

S-EPMC7616389 | biostudies-literature

Divergent mutational processes distinguish hypoxic and normoxic tumours.

Not available